Israel China Biotechnology (ICB) Ltd Working Capital to Net Assets Ratio
Israel China Biotechnology (ICB) Ltd working capital to net assets ratio. Israel China Biotechnology (ICB) Ltd (ICB) has a Working Capital to Net Assets ratio of -89.2% as of June 2021. Working capital of ILA-2.27 Million (current assets of ILA938.00K minus current liabilities of ILA3.21 Million) is measured against net assets of ILA2.55 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Israel China Biotechnology (ICB) Ltd (2015–2020)
Working capital to net assets ratio of Israel China Biotechnology (ICB) Ltd from 2015 to 2020. This chart shows how Israel China Biotechnology (ICB) Ltd's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2015 to 2020. As of June 2021, the ratio stands at -89.2%, reflecting working capital of ILA-2.27 Million against net assets of ILA2.55 Million ILA. Explore Israel China Biotechnology (ICB) Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Israel China Biotechnology (ICB) Ltd Working Capital to Net Assets Ratio by Year (2015–2020)
Israel China Biotechnology (ICB) Ltd working capital to net assets ratio by year from 2015 to 2020. The table below presents the year-by-year Working Capital to Net Assets ratio for Israel China Biotechnology (ICB) Ltd from 2015 to 2020, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Israel China Biotechnology (ICB) Ltd assets under control.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | -949.1% | ILA-4.46 Million | ILA470.00K | ILA2.13 Million | ILA6.59 Million | ▼ -792.8 pp |
| 2019 | -156.4% | ILA-2.95 Million | ILA1.89 Million | ILA4.41 Million | ILA7.36 Million | ▼ -218.2 pp |
| 2018 | 61.9% | ILA4.58 Million | ILA7.41 Million | ILA5.79 Million | ILA1.21 Million | ▲ +67.0 pp |
| 2017 | -5.2% | ILA87.00K | ILA-1.69 Million | ILA1.13 Million | ILA1.05 Million | ▼ -179.3 pp |
| 2016 | 174.1% | ILA3.32 Million | ILA1.91 Million | ILA3.66 Million | ILA344.00K | ▲ +53.2 pp |
| 2015 | 120.9% | ILA6.99 Million | ILA5.78 Million | ILA7.54 Million | ILA546.00K | — |